Dr. Zachary Klaassen and UroToday have provided us with four more interesting summaries of presentations by faculty at the European Association for Urology (EAU)’s meeting in Vienna last weekend. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: biomarkers, care, focal, functional, genomics, imaging, molecular, patient-centered, therapy | 4 Comments »
The next CureTalk program on prostate cancer is scheduled for January 20, 2015, at 5:00 p.m. Eastern time in the USA. The featured speaker is Dr. James Mohler of the Roswell Park Cancer Center in Buffalo, New York. To register for this program, … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: biomarkers, CureTalk, imaging, Mohler | Leave a comment »
Whatever one’s views on the relative merits of mass screening or carefully targeted, risk-based testing, there is little doubt that we need to do better in deciding who to biopsy once prostate cancer is suspected and who to treat when it is identified. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: biomarkers, decision-making, Diagnosis, prognosis | Leave a comment »
A number of readers may be interested in an article by Yadav et al. in the January issue of AUA News, entitled “Genomics at the forefront of biomarker development for prostate cancer detection and therapeutics.” … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: biomarkers, Diagnosis, Treatment | Leave a comment »
A series of summary reports from the first day of the 14th annual meeting of the Society for Urologic Oncology (SUO) has recently been made available on the UroToday web site (which is freely accessible to patients, but you do have to register to access it). … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: biomarkers, research, SUO, utility | Leave a comment »
In today’s news reports we address recent publications on:
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active surveillance, biomarkers, continence, exercise, GEMCaP, radical prostatectomy, radiotherapy, RP, under-staging | 3 Comments »
Nogueira et al. have just published a new “mini-review” in BJU International that addresses the potential roles of current and “future” biomarkers that may have relevance to prostate cancer detection. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: biomarkers, detection | Leave a comment »
Today’s news reports refer to a series of reviews that appeared this month in a supplement to Urology as well as other articles:
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: biomarkers, choice, Diagnosis, outcome, prognosis, PSA, quality of life, risk, survival, Treatment | Leave a comment »
Assiduous readers of this blog will have noted that there are relatively frequent mentions of “new” biomarkers that may have potential as indicators of the aggressiveness of prostate cancer — but that in most cases those biomarkers are never heard of again. … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Risk | Tagged: biomarkers | 1 Comment »
We are returning to “normal” today with the standard “news reports.” Today’s items deal with:
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: agonist, antagonist, biomarkers, gefitinib, Iressa, LHRH, magnetic resonance imaging, MRI | 2 Comments »
The second set of reports in today’s news commentaries encompasses new nomograms, possible new biomarkers, a specific subtype of prostate cancer, and the “hedgehog” signaling pathway. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: biomarkers, ETS fusion, hedgehog signaling, ionized serum calcium, nomogram, recurrence, surgeon experience, survival | Leave a comment »
Some interesting new reports today include:
Filed under: Diagnosis, Drugs in development, Management, Prevention | Tagged: Agaricus bazei, biomarkers, brachytherapy, finasteride, MRI, Prevention, PSA velocity | Leave a comment »
Prostate cancer reports from the 50th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), being held in Boston, are kindly provided by Eyad Abu-Isa, MD, a resident in radiation oncology at the University of Michigan.
Most of the prostate cancer data presented in today’s scientific sessions were from retrospective reviews and the afternoon genitourinary session was focused on biomarkers and predictors of outcome in prostate cancer. … READ MORE …
Filed under: Management, Treatment | Tagged: biomarkers, external beam radiotherapy, high dose rate brachytherapy | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 